Stompór Tomasz, Zabłocki Marek, Łesiów Mirosław
Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury, Olsztyn, Poland.
Pol Arch Med Wewn. 2013;123(6):314-20. doi: 10.20452/pamw.1782. Epub 2013 May 27.
Osteoporosis is one of the epidemics in modern aging societies. Epidemiological studies indicate that many patients with osteoporosis are also characterized by diminished glomerular filtration rate (GFR), which indicates various degrees of chronic kidney disease (CKD). On the other hand, the status of osteoporosis in the classification of mineral and bone disorders in CKD has not been well defined. In the present paper, we review the epidemiology of osteoporosis in the context of kidney failure, discuss tools used to diagnose osteoporosis in patients with CKD, present data on fracture risk in patients with kidney diseases, and describe the relationship between metabolic bone diseases and the development of vascular calcification. We also present current treatments in osteoporosis with special attention to the outcomes of these treatments in patients with low GFR.
骨质疏松症是现代老龄化社会中的流行病之一。流行病学研究表明,许多骨质疏松症患者还具有肾小球滤过率(GFR)降低的特征,这表明存在不同程度的慢性肾脏病(CKD)。另一方面,骨质疏松症在CKD矿物质和骨代谢紊乱分类中的地位尚未明确界定。在本文中,我们回顾了肾衰竭背景下骨质疏松症的流行病学,讨论了用于诊断CKD患者骨质疏松症的工具,展示了肾病患者骨折风险的数据,并描述了代谢性骨病与血管钙化发展之间的关系。我们还介绍了目前骨质疏松症的治疗方法,并特别关注这些治疗方法在低GFR患者中的疗效。